Pages that link to "Item:Q5121060"
From MaRDI portal
The following pages link to Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions (Q5121060):
Displaying 28 items.
- Covariance adjustment in radomized experiments and observational studies (Q1872611) (← links)
- The adjustment of random baseline measurements in treatment effect estimation (Q2507882) (← links)
- Causal mediation analysis: from simple to more robust strategies for estimation of marginal natural (in)direct effects (Q2683176) (← links)
- Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups (Q3003012) (← links)
- The Effect of a Covariate on Standard Error and Confidence Interval Width (Q3083795) (← links)
- Analysis of covariance with pre-treatment measurements in randomized trials: Comparison of equal and unequal slopes (Q3100764) (← links)
- Analysis of Covariance in Parallel-Group Clinical Trials with Pretreatment Baselines (Q3201543) (← links)
- On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial (Q3303813) (← links)
- Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates (Q3530087) (← links)
- A New Nonparametric Approach for Baseline Covariate Adjustment for Two‐Group Comparative Studies (Q3549402) (← links)
- Choice of Baselines in Clinical Trials: A Simulation Study from Statistical Power Perspective (Q3590007) (← links)
- Covariance and variance evaluations of two estimators for drug–placebo difference in a trial with sequential parallel design (Q4588906) (← links)
- Design and Analysis of Gauge R&R Studies (Q5466644) (← links)
- Comment on ‘Inference after covariate-adaptive randomisation: aspects of methodology and theory’ (Q5880084) (← links)
- Rejoinder on ‘Inference after covariate-adaptive randomization: aspects of methodology and theory’ (Q5880086) (← links)
- Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes (Q6055509) (← links)
- The Generalized Oaxaca-Blinder Estimator (Q6107228) (← links)
- Toward Better Practice of Covariate Adjustment in Analyzing Randomized Clinical Trials (Q6144753) (← links)
- Robust analysis of stepped wedge trials using composite likelihood models (Q6618328) (← links)
- Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects (Q6618379) (← links)
- Categorisation of continuous covariates for stratified randomisation: how should we adjust? (Q6618500) (← links)
- Phases of methodological research in biostatistics -- building the evidence base for new methods (Q6625372) (← links)
- Covariate adjustment in randomized clinical trials with missing covariate and outcome data (Q6626916) (← links)
- Propensity score weighting for covariate adjustment in randomized clinical trials (Q6627930) (← links)
- Constrained randomization and statistical inference for multi-arm parallel cluster randomized controlled trials (Q6628081) (← links)
- Discussion of: ``Target estimands for population-adjusted indirect comparisons'' (Q6629397) (← links)
- Regression analysis for covariate-adaptive randomization: a robust and efficient inference perspective (Q6629407) (← links)
- Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score (Q6637100) (← links)
